Search This Blog

Monday, April 6, 2026

Profusa to acquire BioInsights’ PanOmics multi-omics diagnostics

 

Profusa signs $30M all-equity LOI to acquire BioInsights’ PanOmics multi-omics diagnostics platform, expanding into precision diagnostics

  • Deal is expected to add $30 million of shareholder equity to Profusa’s balance sheet upon completion.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.